Novartis Pharmaceuticals / SuperGen Inc / USA 3SuperGen Inc. / /
Facility
PRC2 complex / Medical College of Georgia / /
MedicalCondition
leukemia / tumor / non-viable cells A. C. K562 cells K562 B. DNMT1 In myeloid leukemia / breast cancers / Cancer / CML blast crisis / human leukemia / tumor suppressor genes / bladder cancers / breast cancer / /
Organization
Redkar3 and Kapil Bhalla1 1MCG Cancer Center / Medical College of Georgia / / /
Anti-AML activity of combined epigenetic therapy with novel DNMT1 inhibitors SGI-110 and SGI1036 and histone deacetylase inhibitor panobinostat. Warren Fiskus1, Pace Johnston1, Rajeshree Joshi1, Rekha Rao1, Celalettin Us